Phase 1 study of FF-21101(90Y), a radioimmunotherapeutic targeting P-cadherin, in advanced solid tumors

Category Primary study
JournalCancer Research
Year 2017
This article has no abstract
Epistemonikos ID: 2f7445a5aa49881b2b510dc6bd64ec5f3867fca9
First added on: Feb 08, 2025